1. ARC (apoptosis repressor with caspase recruitment domain) deficient mice develops severe knee joint histopathology but demonstrates reduced mechanical allodynia after surgically-induced osteoarthritis. (April 2019) Authors: Shu, C.C.; Liu, Y.; Stoner, S.P.; Smith, S.M.; Ashton, A.W.; Little, C.B. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Differential patterns of pathology in and interaction between joint tissues in long-term osteoarthritis with different initiating causes: phenotype matters. Issue 7 (July 2020) Authors: Zaki, S.; Smith, M.M.; Smith, S.M.; Little, C.B. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 7(2020) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the potential chondroprotective effects of 26S proteasome inhibitors in an in vitro cartilage explant model. (April 2018) Authors: SHU, C.C.; Ravi, V.; Liu, Y.; Smith, S.M.; Ashton, A.W.; Little, C.B. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Models of injury and osteoarthritis: the role of impact severity and joint instability. (April 2016) Authors: Blaker, C.; Little, C.B.; Smith, S.M.; Clarke, E.C. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PAIN MEDICATION USE IN OLDER IRISH ADULTS WITH OSTEOARTHRITIS FROM THE IRISH LONGITUDINAL STUDY ON AGEING (TILDA): A CROSS-SECTIONAL STUDY. (April 2022) Authors: French, H.P.; Cunningham, J.; Cahir, C.; Cadogan, C.; Clyne, B.; Doyle, F.; Ryan, J.M.; Smith, S.M.; Bennett, K.E. Journal: Osteoarthritis and cartilage Issue: Volume 30(2022)Supplement 1 Page Start: S374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PRIMARY CARE-BASED MODELS OF CARE FOR OSTEOARTHRITIS: A SCOPING REVIEW. (April 2022) Authors: Cunningham, J.; Doyle, F.; Ryan, J.M.; Clyne, B.; Cadogan, C.; Cottrell, E.; Smith, S.M.; French, H.P. Journal: Osteoarthritis and cartilage Issue: Volume 30(2022)Supplement 1 Page Start: S387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RAPID AND DURABLE RESPONSES WITH THE SYK/JAK INHIBITOR CERDULATINIB IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA—ALONE OR IN COMBINATION WITH RITUXIMAB. (12th June 2019) Authors: Smith, S.D.; Munoz, J.; Stevens, D.A.; Smith, S.M.; Feldman, T.A.; Ye, J.C.; de Vos, S.; Hess, B.T.; Miller, C.B.; Khatcheressian, J.L.; Birrell, M.R.; Leeds, J.M.; Coffey, G.P.; Conley, P.B.; Michelson, G.C.; Curnutte, J.T.; Hamlin, P.A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES. (June 2017) Authors: Hamlin, P.A.; Farber, C.M.; Fenske, T.S.; Khatcheressian, J.L.; Miller, C.B.; Munoz, J.; Patel, M.R.; Schreeder, M.T.; Smith, S.M.; Stevens, D.A.; Pandey, A.; Birrell, M.R.; Leeds, J.M.; Wang, Y.L.; Coffey, G.P.; Curnutte, J.T. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effects of intra-articular injection of mesenchymal stem cells versus hyaluronan hexadecylamide-derivative on post-traumatic OA: the relationship between synovial inflammation, structural pathology and pain sensitisation. (April 2016) Authors: Shu, C.C.; Ravi, V.; Zaki, S.; Smith, S.M.; Schiavinato, A.; Smith, M.M.; Little, C.B. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THE FIRST‐IN‐CLASS ANTI‐CD47 ANTIBODY HU5F9‐G4 + RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS. (12th June 2019) Authors: Advani, R.; Bartlett, N.L.; Smith, S.M.; Roschewski, M.; Popplewell, L.; Flinn, I.; Collins, G.; Ghosh, N.; LaCasce, A.; Asch, A.; Kline, J.; Kesevan, M.; Tran, T.; Lynn, J.; Huang, J.; Agoram, B.; Volkmer, J.; Takimoto, C.H.; Chao, M.P.; Mehta, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗